The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2020

Filed:

Jun. 13, 2017
Applicant:

Translate Bio, Inc., Cambridge, MA (US);

Inventors:

Frank DeRosa, Cambridge, MA (US);

Michael Heartlein, Cambridge, MA (US);

Lianne Smith, Cambridge, MA (US);

Shrirang Karve, Cambridge, MA (US);

Assignee:

Translate Bio, Inc., Lexington, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/45 (2006.01); C12N 9/10 (2006.01); A61K 48/00 (2006.01); A61K 9/00 (2006.01); A61K 9/127 (2006.01);
U.S. Cl.
CPC ...
A61K 38/45 (2013.01); A61K 9/0019 (2013.01); A61K 9/1272 (2013.01); A61K 48/0058 (2013.01); C12N 9/1018 (2013.01); C12Y 201/03003 (2013.01); A61K 48/00 (2013.01);
Abstract

The present invention provides, among other things, methods of treating ornithine transcarbamylase (OTC) deficiency, including administering to a subject in need of treatment a composition comprising an mRNA encoding an ornithine transcarbamylase (OTC) protein at an effective dose and an administration interval such that at least one symptom or feature of the OTC deficiency is reduced in intensity, severity, or frequency or has delayed onset. In some embodiments, the mRNA is encapsulated in a liposome comprising one or more cationic lipids, one or more non-cationic lipids, one or more cholesterol-based lipids and one or more PEG-modified lipids.


Find Patent Forward Citations

Loading…